Search Results 11-20 of 14277 for ������������������������������������������������r���:za33���
The purpose of this study is to learn about the effects of a research medicine called AFM13 and to see how well AFM13 is tolerated. Participation eligibility.
... (R/M) HPV-16 positive advanced malignancies including oropharyngeal SCCHN. The purpose of Phase II part 2 is to compare the Progression-Free Survival (PFS) ...
About this study. This open-label, randomized study will compare the efficacy of GDC-0199 plus rituximab (GDC-0199+R) with bendamustine plus ...
Kukla A, Lester SC, Iqbal A, Razonable RR, Issa N, Riad S, Fox JC, Prieto M, Kudva YC. Pancreas irradiation for treatment-resistant acute cellular rejection ...
This ongoing condition can affect more than just the joints. It also can damage skin, eyes, lungs, heart and blood vessels.
... R, Szymanski J, Longo N, Bayrak-Toydemir P. Parkes Weber syndrome associated ... R, Fryer TD, Hong YT, Aigbirhio FI, Rowe JB, O'Brien JT. Correlation ...
Liu K, Chang CE, Lloyd S, Tao R, Nguyen T, Zhang ZF, Hashibe M. The Risk of Type 2 Diabetes among Older Asian, Native Hawaiian, and Pacific Islander ...
Raymund R. Razonable, M.D. · Infectious Disease Specialist · Vice Chair, Infectious Diseases, Minnesota.
... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...
Baral B, Suleiman R, Fazer-Posorske CA, Ma DJ, McGarrah PW, Thome SD, Molina JR, Price KA, Halfdanarson TR, Fuentes HE. Advancing head and neck cancer ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.